Lack of Pharmacokinetic Interactions Between Moxonidine and Digoxin
Authors:
- 1 December 1992
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 23 (6) , 477-481
Abstract
The potential for pharmacokinetic interactions between moxonidine and digoxin at steady-state was investigated in 15 healthy male volunteers. Multiple oral doses of 0.2mg moxonidine twice daily and 0.2mg digoxin once daily were administered alone and in combination in a randomised 3-period crossover design. The drugs were administered for at least 5 days. The results indicate that neither moxonidine nor digoxin influences the pharmacokinetics of the other drug under steady-state conditions.Keywords
This publication has 9 references indexed in Scilit:
- Lack of pharmacokinetic interaction as an equivalence problem.1991
- Absolute bioavailability of moxonidineEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- [Long-term experiences with moxonidine, a new antihypertensive agent].1990
- UNIQUE PRESYNAPTIC ALPHA-2-RECEPTOR SELECTIVITY AND SPECIFICITY OF THE ANTIHYPERTENSIVE AGENT MOXONIDINE1988
- The Influence of Renal Function on Clinical Pharmacokinetics of MoxonidineClinical Pharmacokinetics, 1988
- Pharmacokinetics of Moxonidine After Single and Repeated Daily Doses in Healthy VolunteersThe Journal of Clinical Pharmacology, 1987
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- On clinically relevant differences and shifted null hypotheses.1987
- Confidence intervals rather than P values: estimation rather than hypothesis testing.BMJ, 1986